The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

RCJ Bradlow, M Berk, PW Kalivas, SE Back… - CNS drugs, 2022 - Springer
Abstract N-acetyl-L-cysteine (NAC) is a compound of increasing interest in the treatment of
psychiatric disorders. Primarily through its antioxidant, anti-inflammatory, and glutamate …

Pharmacological treatment of obsessive-compulsive disorder

C Pittenger, MH Bloch - Psychiatric Clinics, 2014 - psych.theclinics.com
Obsessive-compulsive disorder (OCD) can present a significant management challenge to
the clinical psychiatrist. OCD affects approximately 1.3% of the population in any given year …

[HTML][HTML] Treatment-resistant OCD: Pharmacotherapies in adults

PJ Van Roessel, G Grassi, EN Aboujaoude… - Comprehensive …, 2023 - Elsevier
Serotonin reuptake inhibitor (SRI) medications are well established as first-line
pharmacotherapeutic treatment for Obsessive-Compulsive Disorder (OCD). However …

[PDF][PDF] Mapping compulsivity in the DSM-5 obsessive compulsive and related disorders: cognitive domains, neural circuitry, and treatment

NA Fineberg, AM Apergis-Schoute… - International Journal …, 2018 - academic.oup.com
Compulsions are repetitive, stereotyped thoughts and behaviors designed to reduce harm.
Growing evidence suggests that the neurocognitive mechanisms mediating behavioral …

N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects

A Minarini, S Ferrari, M Galletti… - Expert Opinion on …, 2017 - Taylor & Francis
ABSTRACT Introduction: N-acetylcysteine (NAC) is widely known for its role as a mucolytic
and as an antidote to paracetamol overdose. There is increasing interest in the use of NAC …

N‐acetylcysteine augmentation therapy for moderate‐to‐severe obsessive–compulsive disorder: Randomized, double‐blind, placebo‐controlled trial

K Paydary, A Akamaloo, A Ahmadipour… - Journal of clinical …, 2016 - Wiley Online Library
What is known and objective N‐acetylcysteine (NAC) has been proposed as a potential
therapy for obsessive–compulsive disorder (OCD) as it may regulate the exchange of …

N‐acetylcysteine as a new prominent approach for treating psychiatric disorders

I Smaga, M Frankowska, M Filip - British Journal of …, 2021 - Wiley Online Library
N‐acetylcysteine (NAC) is a well‐known and safe mucolytic agent, also used in patients with
paracetamol overdose. In addition to these effects, recent preclinical and clinical studies …

N‐acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta‐analysis

MS Duailibi, Q Cordeiro, E Brietzke… - … American journal on …, 2017 - Wiley Online Library
Background and Objectives Recent neurobiological evidences along with clinical
observations justify the use of N‐acetylcysteine (NAC) as a medication for craving. The …

Investigating the role of glutamate in obsessive-compulsive disorder: current perspectives

S Karthik, LP Sharma… - … disease and treatment, 2020 - Taylor & Francis
Glutamate is a ubiquitous excitatory neurotransmitter, which is involved in normal
physiology, a variety of central nervous system (CNS) functions, including excitotoxicity and …

Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder

DLC Costa, JB Diniz, G Requena… - The Journal of clinical …, 2017 - psychiatrist.com
Objective: To evaluate the efficacy of serotonin reuptake inhibitor (SRI) augmentation with N-
acetylcysteine (NAC), a glutamate modulator and antioxidant medication, for treatment …